Yasmin and YAZ Class Action Settlement

Yasmin and YAZ Class Action Settlement

If you are a resident of Canada who was prescribed and ingested Yasmin between December 10, 2004 and/or YAZ between January 6, 2009, and:

  • November 30, 2011, if you reside in Ontario or Quebec, or
  • October 4, 2016, if you reside in Canada but outside Ontario or Quebec

AND you were subsequently diagnosed with one or more of the following conditions:

  • Arterial thromboembolism
  • Venous thromboembolism
  • Gallbladder disease

OR a resident of Canada who, by virtue of a personal relationship with any individual described above, has a derivative claim for damages under Canadian family law legislation.

Then your rights may be affected as part of this class action.

Overview of the Class Action

A Canada-wide settlement has been reached with Bayer Inc. and other Bayer defendants in class actions commenced in Ontario, Saskatchewan, and Quebec relating to the oral contraceptives Yasmin and YAZ. The class actions raised various allegations relating to blood clots and gallbladder disease and removal. Bayer denies the allegations made in the class actions, makes no admission as to the truth of these allegations, and denies any wrongdoing.

What is the Settlement?

Under the Settlement, Bayer will provide an all-inclusive Settlement Fund of CAD $9,050,000.00. The Settlement Fund will be used, among other things, to pay the costs of notice and administration of the Settlement, the claims of Provincial Health Insurers, Class Counsel legal fees, and benefits for Approved Claimants who are part of the Settlement Class. The final value of benefits for each Approved Claimant will not be determined until all Claims are submitted and considered by the Claims Administrator.

For the Settlement to become effective, it must be approved by the Ontario Superior Court of Justice, the Superior Court of Québec, and the Court of King’s Bench for Saskatchewan. These Courts must be satisfied that the Settlement is fair, reasonable, and in the best interest of the Settlement Class. The Settlement Approval Hearing before the Court of King’s Bench for Saskatchewan on November 21, 2025, has been adjourned and will instead take place on February 11, 2026, at 2 p.m., at the Courthouse in Saskatoon. (Hearings before the Ontario Superior Court of Justice and Superior Court of Québec have already taken place.)

In the event that the Settlement is not approved by the Courts in a form agreed to by the Plaintiffs and Defendants, the Settlement Agreement will terminate, and its terms will no longer be binding on the Settlement Class. In that case, all parties will be restored to their pre-Settlement Agreement positions.

Who is included?

For the purposes of the Settlement, the Settlement Class is comprised of:

  • all persons resident in Canada who were prescribed and ingested Yasmin and/or YAZ between December 10, 2004 (in respect of Yasmin) or January 6, 2009 (in respect of YAZ) and
    • November 30, 2011 (in the case of Ontario and Québec residents) or
    • October 4, 2016 (in the case of Canadian residents outside Ontario and Québec)

AND who were subsequently diagnosed with arterial thromboembolism, venous thromboembolism, and/or gallbladder disease;

  • As well as all persons resident in Canada who, by virtue of a personal relationship to any one or more of the persons described above, has a derivative claim for damages under Canadian family law legislation.

Summary of Your Legal Rights and Options

Do Nothing

Class Members who did not submit an opt-out request are automatically included in the class action and no action is required at this time.

If the proposed settlement receives court approval, a formal claims process will be initiated, and additional details will be provided at that stage.

Object to the Settlement

The deadline to submit objections to the Settlement for the Ontario Superior Court of Justice and the Superior Court of Québec has passed.

However, if you wish to object to the proposed Settlement in the Court of King’s Bench for Saskatchewan, you must submit a written objection no later than 5:00 p.m. Eastern Standard Time on January 15, 2026, containing the following information:

  • a heading that states “Objection to Yasmin/YAZ Class Actions National Settlement”
  • your full name, current mailing address, telephone number, and email address
  • a brief explanation of the nature and reasons for your objection, along with any supporting documents
  • a declaration that you believe you are a member of the Settlement Class and the reason for that belief
  • whether you intend to appear at the Settlement Approval Hearing(s), in which Province you plan to attend, and, if you intend to appear represented by counsel, the name, address, telephone number, and email address of your counsel; and
  • your signature

Your written objection must be received by the Claims Administrator via pre-paid mail, courier, or email by no later than 5:00 p.m. Eastern Standard Time on January 15, 2026 to:

Epiq Class Action Services Canada Inc.
Attention: YAZ/Yasmin Class Action
P.O. Box 507 STN B
Ottawa, ON K1P 5P6
Email: Objection@YasminYazClassActionCanada.ca

The Claims Administrator will file copies of the objections received on time with the Courts.

If you plan to attend a Settlement Approval Hearing and you have submitted a written objection, you may request to make oral submissions to the Court in your objection letter.

We recommend you review the FAQ Page for further details about this class action.
Important Updates:

The deadline to object to the Settlement for the Ontario Superior Court of Justice, and the Superior Court of Québec was on October 14, 2025.

The deadline to object to the Settlement in the Court of King’s Bench for Saskatchewan was on January 15, 2026.

The Claims Administrator is no longer accepting objections to the Settlement.

Settlement Approval Hearing

The Settlement Approval Hearing before the Court of King’s Bench for Saskatchewan will be held on February 11, 2026.